Kivodoxo-M
Description_Effects
Kivodoxo-M is a combination medicine containing Doxofylline and Montelukast, designed to improve breathing and manage symptoms related to asthma and allergic respiratory conditions. Doxofylline acts as a bronchodilator by relaxing the muscles surrounding the airways, which widens them and allows air to flow more freely. This helps reduce breathing difficulties such as wheezing, chest tightness, and shortness of breath. Montelukast is a leukotriene receptor antagonist that blocks the effects of leukotrienes, chemical messengers that cause inflammation and swelling in the airways. By inhibiting leukotrienes, Montelukast helps reduce airway inflammation, preventing asthma attacks and alleviating allergy symptoms like nasal congestion and sneezing. This dual action helps control and prevent episodes of asthma and improves overall lung function. Kivodoxo-M is often prescribed for long-term management of asthma and allergic conditions to reduce symptoms and improve quality of life. Consistent use as directed by a healthcare professional is important for optimal control of respiratory symptoms. Patients should inform their doctor about any other medications or health issues before starting Kivodoxo-M. Proper use can help prevent asthma attacks, ease breathing, and allow for a more active and comfortable lifestyle.
